or
forgot password
  • cancer clinical trials in tulsa, OK

  • Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Pancreatic Cancer
    Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Cervical Cancer, Endometrial Cancer, Lymphedema, Vulvar Cancer
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 129
    Tulsa, Oklahoma 74104
    Hypoactive Sexual Desire Disorder
    Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Metastatic Breast Cancer, Locally Advanced Breast Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Breast Cancer
    Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
    Cancer Care Associates-Tulsa
    Tulsa, Oklahoma 74136
    Extensive-stage Small Cell Lung Cancer
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Cancer Care Associates
    Tulsa, Oklahoma 74136
    Myelodysplastic Syndrome (MDS)
    rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study
    Central States Orthopedic Specialists
    Tulsa, Oklahoma 74136
    Degenerative Disc Disease
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Cancer Treatment Centers of America- Southwestern Regional Medical Center
    Tulsa, Oklahoma 74133
    Ovarian Cancer
    A Retrospective Review of Malignant Liver Tumors
    The University of Oklahoma College of Medicine, Tulsa - Department of Surgery
    Tulsa, Oklahoma 74135
    Liver Cancer
    Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
    Heartland Health Institute
    Tulsa, Oklahoma 74105
    Genital Warts
    Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Lung Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Options Health Research
    Tulsa, Oklahoma 74104
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Options Health Research
    Tulsa, Oklahoma 74104
    Ulcerative Colitis
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Endometrial Cancer
    Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
    Cancer Care Associates
    Tulsa, Oklahoma 74136
    Fatigue, Chemotherapy Side Effects
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Rheumatoid Arthritis
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Natalie W Bryant Cancer Center
    Tulsa, Oklahoma 74136
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Ovarian Cancer, Non Small Cell Lung Cancer, Prostate Cancer, Colorectal Cancer, Gastric Cancer, Esophageal Cancer, Cancer of Head and Neck
    Notch Inhibitor in Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Advanced Cancer
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Colorectal Cancer, Metastatic Cancer
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Cancer Care Associates-Yale
    Tulsa, Oklahoma 74136-1929
    Endometrial Cancer
    Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Solid Tumors
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    Cancer Care Associates-Yale
    Tulsa, Oklahoma 74136-1929
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
    Options Health Research
    Tulsa, Oklahoma 74104
    Crohn's Disease
    BIBF 1120 in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Cancer Care Associates-Yale
    Tulsa, Oklahoma 74136-1929
    Endometrial Cancer
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Cancer Care Associates

    Trial Locations
    Cancer Care Associates
    Mercy Physicians of Oklahoma
    Locally Recurrent or Metastatic Breast Cancer
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    Neurological Associates of Tulsa, Inc
    Tulsa, Oklahoma 74137
    Multiple Sclerosis
    Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
    Options Health Research, Llc
    Tulsa, Oklahoma 74104
    Crohn's Disease
    A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

    Tulsa, Oklahoma
    Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer